229 related articles for article (PubMed ID: 9021665)
1. [Reproductive and developmental toxicity study of a new antineoplastic agent, S-1 (III)--Teratological study in rabbits by oral administration].
Shinomiya M; Yukiyama S; Ikebuchi K
J Toxicol Sci; 1996 Nov; 21 Suppl 3():619-41. PubMed ID: 9021665
[TBL] [Abstract][Full Text] [Related]
2. [Reproductive and developmental toxicity study of a new antineoplastic agent, S-1 (II)--Teratological study in rats by oral administration].
Yukiyama S; Shinomiya M; Ikebuchi K; Sato T
J Toxicol Sci; 1996 Nov; 21 Suppl 3():603-18. PubMed ID: 9021664
[TBL] [Abstract][Full Text] [Related]
3. [Reproductive and developmental toxicity study of a new antineoplastic agent, S-1 (I)--Fertility study in rats by oral administration].
Shinomiya M; Imamura K; Izumi K
J Toxicol Sci; 1996 Nov; 21 Suppl 3():589-602. PubMed ID: 9021663
[TBL] [Abstract][Full Text] [Related]
4. [Reproductive and developmental toxicity study of a new antineoplastic agent, S-1 (IV)--Perinatal and postnatal study in rats by oral administration].
Furuhashi T; Kato M; Fujimura T; Koida M
J Toxicol Sci; 1996 Nov; 21 Suppl 3():643-59. PubMed ID: 9021666
[TBL] [Abstract][Full Text] [Related]
5. [An oral repeated dose toxicity study of a new antineoplastic agent S-1 in dogs. I. A 13-week repeated dose toxicity study. II. An ophthalmologic toxicity recovery study].
Hayashi T; Yamaguchi S; Kito S; Tanaka G; Kurokawa K; Hirota T
J Toxicol Sci; 1996 Nov; 21 Suppl 3():527-44. PubMed ID: 9021660
[TBL] [Abstract][Full Text] [Related]
6. [A 13-week oral repeated dose toxicity study of a new antineoplastic agent S-1 in rats].
Hayashi T; Hasegawa H; Tanaka G; Ohmae S
J Toxicol Sci; 1996 Nov; 21 Suppl 3():505-26. PubMed ID: 9021659
[TBL] [Abstract][Full Text] [Related]
7. [Oral single-dose toxicity study of a new antineoplastic agent S-1, and its components, CDHP, and Oxo].
Hayashi T; Tanaka G; Irimura K; Hirota T; Ohmae S
J Toxicol Sci; 1996 Nov; 21 Suppl 3():495-504. PubMed ID: 9021658
[TBL] [Abstract][Full Text] [Related]
8. [A 26-week oral repeated dose toxicity study of a new antineoplastic agent S-1 in rats].
Hakoi K; Hayashi T; Ohmae S; Besshi K
J Toxicol Sci; 1996 Nov; 21 Suppl 3():545-60. PubMed ID: 9021661
[TBL] [Abstract][Full Text] [Related]
9. [Reproductive and developmental toxicity studies of taltirelin hydrate (3) teratogenicity study in rabbits by oral administration].
Imahie H; Nishida A; Imado N; Asano Y
J Toxicol Sci; 1997 Nov; 22 Suppl 2():395-403. PubMed ID: 9430097
[TBL] [Abstract][Full Text] [Related]
10. [Reproductive and developmental toxicity study of suplatast tosilate (IPD-1151T) (3)--Teratological study in rabbits by oral administration].
Yamakita O; Shinomiya M; Kurokawa M; Koida M; Mizutani T; Nakagawa M; Manabe H; Sugimoto S
J Toxicol Sci; 1992 May; 17 Suppl 2():175-85. PubMed ID: 1321260
[TBL] [Abstract][Full Text] [Related]
11. [Mutagenicity study of a new antineoplastic agent S-1, and its components, CDHP, and Oxo].
Ohuchida A; Kouchi Y; Sato S; Maeda Y
J Toxicol Sci; 1996 Nov; 21 Suppl 3():675-89. PubMed ID: 9021668
[TBL] [Abstract][Full Text] [Related]
12. [A 52-week oral toxicity study of a new antineoplastic agent S-1 in dogs].
Kitajima S; Okamura T; Kobayashi K; Watari N; Inoue H; Enomoto M; Yamaguchi S
J Toxicol Sci; 1996 Nov; 21 Suppl 3():561-88. PubMed ID: 9021662
[TBL] [Abstract][Full Text] [Related]
13. [Reproduction study of 1,1,3-trimethyl-5-phenylbiuret (ST-281): teratological study in rabbits by oral administration].
Yamakita O; Yoshida R; Shinomiya M; Koida M; Imamura K; Kashihara A; Morita K
J Toxicol Sci; 1986 May; 11 Suppl 2():71-80. PubMed ID: 3761404
[TBL] [Abstract][Full Text] [Related]
14. [Reproductive and developmental toxicity study of mofezolac (N-22) (3)--Teratogenicity study in rabbits by oral administration].
Fuchigami K; Otsuka T; Sameshima K; Matsunaga K; Kodama R; Yamakita O
J Toxicol Sci; 1990 Jun; 15 Suppl 2():209-18. PubMed ID: 2231790
[TBL] [Abstract][Full Text] [Related]
15. Increased intestinal permeability correlates with gastrointestinal toxicity among formulations of the fluorouracil analogue tegafur in rats.
Korenaga D; Honda M; Yasuda M; Inutsuka S; Nozoe T; Tashiro H
Eur Surg Res; 2002; 34(5):351-6. PubMed ID: 12364819
[TBL] [Abstract][Full Text] [Related]
16. Reproductive safety studies with genistein in rats.
McClain RM; Wolz E; Davidovich A; Edwards J; Bausch J
Food Chem Toxicol; 2007 Aug; 45(8):1319-32. PubMed ID: 17433519
[TBL] [Abstract][Full Text] [Related]
17. The effect of food on the pharmacokinetics of S-1 after single oral administration to patients with solid tumors.
Peters GJ; Noordhuis P; Van Groeningen CJ; Giaccone G; Holwerda U; Voorn D; Schrijvers A; Schornagel JH; Beijnen JH; Fumoleau P; Schellens JH
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4072-6. PubMed ID: 15217941
[TBL] [Abstract][Full Text] [Related]
18. [New oral anticancer drug, TS-1 (S-1)--from bench to clinic].
Shirasaka T; Tsukuda M; Inuyama Y; Taguchi T
Gan To Kagaku Ryoho; 2001 Jun; 28(6):855-64. PubMed ID: 11432358
[TBL] [Abstract][Full Text] [Related]
19. [Immunotoxic effects of a new antineoplastic agent S-1 in mice--comparison with S-1, UFT and 5-FU].
Kouchi Y; Maeda Y; Morinaga H; Ohuchida A
J Toxicol Sci; 1996 Nov; 21 Suppl 3():691-701. PubMed ID: 9021669
[TBL] [Abstract][Full Text] [Related]
20. Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies.
Chu QS; Hammond LA; Schwartz G; Ochoa L; Rha SY; Denis L; Molpus K; Roedig B; Letrent SP; Damle B; DeCillis AP; Rowinsky EK
Clin Cancer Res; 2004 Aug; 10(15):4913-21. PubMed ID: 15297391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
